Back
Axos Financial Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Buy
63
AX
Axos Financial
Last Price:
66.51
Seasonality Move:
11.86%
Sell
47
RARE
Ultragenyx Pharmaceutical
Last Price:
54.79
Seasonality Move:
12.42%
Buy
63
Axos Financial (AX)
is a Buy
Is Axos Financial a Buy, Sell or Hold?
- The current Axos Financial [AX] share price is $65.64. The Score for AX is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- AX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
47
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $54.69. The Score for RARE is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AX Stock Price Chart
What is Axos Financial's stock price today?
-
The Axos Financial share price today is $65.64
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AX is experiencing slight buying pressure.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $54.69
The current trend is moderately bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.
AX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.47 | Buy |
| Relative Strength Index (14 RSI): | 54.6 | Buy |
| Chaikin Money Flow: | 86138 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (61.14 - 66.14) | Buy |
| Bollinger Bands (100): | (56.49 - 69.19) | Buy |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 46.74 | Sell |
| Chaikin Money Flow: | -417236 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (53.89 - 57.39) | Sell |
| Bollinger Bands (100): | (42.72 - 56.34) | Buy |
AX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 65.63 | Buy |
| 20-day SMA: | 63.01 | Buy |
| 50-day SMA: | 64.38 | Buy |
| 200-day SMA: | 58.2 | Buy |
| 8-day EMA: | 65.08 | Buy |
| 20-day EMA: | 64.18 | Buy |
| 50-day EMA: | 64.02 | Buy |
| 200-day EMA: | 58.45 | Buy |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 55.79 | Sell |
| 20-day SMA: | 55.04 | Sell |
| 50-day SMA: | 55.76 | Sell |
| 200-day SMA: | 47.58 | Buy |
| 8-day EMA: | 55.24 | Sell |
| 20-day EMA: | 55.36 | Sell |
| 50-day EMA: | 54.2 | Buy |
| 200-day EMA: | 48.52 | Buy |
Axos Financial Earnings Growth & AX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.54 per share, and an increase next year of $0.33 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.05 per share, and an increase next year of $1.10 per share.
Axos Financial Technical Analysis
| Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical Technical Analysis
| Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||